Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yu Zhu
Observed name:
Yu Bing Zhu
Institutions:
Jiangsu Cancer Hospital,
Jiangsu Province Hospital,
Nanjing Medical University
Observed institutions:
Kunming Medical University,
Shanghai Changzheng Hospital,
First Affiliated Hospital of Kunming Medical University,
Jiangsu Cancer Hospital,
Jiangsu Province Hospital,
Nanjing First Hospital,
Nanjing Medical University
show all 7
ORCID:
0000-0002-8875-4629
Observed ORCID:
0000-0002-8875-4629
OpenAlex ID:
A5079753783
New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer’s Disease
2018
·
Kai Long Zhong
, Fang Chen
, et al.
·
Metabolic Brain Disease
·
33
Platelet-derived exosomal LINC00183 facilitate colorectal cancer malignant progression driven by histone lactylation through stabilizing ENO1
2025
·
Guoqing Su
, Jinghang Qian
, et al.
·
Cell Death and Disease
·
17
PDF
Optimizing olverembatinib dose in chronic phase chronic myeloid leukemia
2025
·
Xiaoshuai Zhang
, Yunfan Yang
, et al.
·
Haematologica
·
12
PDF
A 5-Year Follow-up Clinical Study of the B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy HDS269B in Patients with Relapsed or Refractory Multiple Myeloma
2024
·
Dongjian Chen
, Yu Zhu
, et al.
·
Clinical Cancer Research
·
12
PDF
Characteristics and prognostic value of extramedullary chromosomal abnormalities in extramedullary myeloma
2022
·
Yuan Xia
, Yu Shi
, et al.
·
Chinese Medical Journal
·
11
Clinical Pharmacology and Side Effects of Venetoclax in Hematologic Malignancies
2024
·
Yuting Yan
, Yujiao Guo
, et al.
·
Current Drug Metabolism
·
10
Preclinical Studies and Phase II Trial of Venetoclax in Combination with Chidamide and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia
2022
·
Jie Zha
, Hui Zhou
, et al.
·
Blood
·
8
Outcomes of allogeneic hematopoietic stem cell transplantation versus intensive chemotherapy in patients with myeloid sarcoma: a nationwide representative multicenter study
2024
·
Jie Sun
, Yi-Cheng Zhang
, et al.
·
Bone Marrow Transplantation
·
6
Relationships between optic nerve damage and the severity of cognitive impairment in patients with mild cognitive impairment and Alzheimer's disease
2017
·
Lina Zhang
, Yuming Xu
, et al.
·
Biomedical Research-tokyo
·
4
Correction: Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells
2020
·
Hao Yang
, Hui Hui
, et al.
·
Oncotarget
·
3
PDF
The combination therapy of imatinib and dasatinib achieves longterm molecular response in two imatinib-resistant and dasatinibintolerant patients with advanced chronic myeloid leukemia
2016
·
Yu Zhu
, Liangqin Pan
, et al.
·
Journal of Biomedical Research
·
3
Functional Evaluation of KEL as an Oncogenic Gene in the Progression of Acute Erythroleukemia
2021
·
Zijuan Wu
, Wenjie Liu
, et al.
·
Research Square
·
2
PDF
Benchmark evaluation of large language models in acute myeloid leukemia prognosis
2025
·
Xiangjie Lin
, Di Xu
, et al.
·
Blood
·
1
Data from A 5-Year Follow-up Clinical Study of the B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy HDS269B in Patients with Relapsed or Refractory Multiple Myeloma
2024
·
Dongjian Chen
, Yu Zhu
, et al.
·
1
Acute kidney injury in peripheral blood haploidentical hematopoietic stem cell transplantation: should attract enough attention
2022
·
Yanping Liu
, Ziwen Duan
, et al.
·
Bone Marrow Transplantation
·
1
Prognostic factors for newly diagnosed Acute Myeloid Leukemia with FLT3-TKD - a multicenter retrospective study
2025
·
Jiaying Lian
, Yu Zhu
, et al.
·
Blood
PDF
Preclinical and clinical Study of olverembatinib in patients with myeloid/lymphoid neoplasms with FGFR1 rearrangement
2025
·
Wenzhi CAI
, Yan Xiong
, et al.
·
Blood
PDF
Construction and evaluation of a prognostic model for patients with Acute Myeloid Leukemia
2025
·
Feng Zhu
, Yile Zhou
, et al.
·
Blood
Characteristics and clinical outcomes of ND-AML patients with bcor/bcorl1 mutations
2025
·
Shaolei Zang
, Chunyan Ji
, et al.
·
Blood
Real-world effectiveness and safety of gilteritinib plus venetoclax and azacitidine in FLT3 mutated acute myeloid leukemia
2025
·
Nianci Chen
, Yu Zhu
, et al.
·
Blood
PDF
Treatment-free remission outcomes in pediatric chronic myeloid leukemia: Second-generation TKIs vs. Imatinib–a real-world multicenter study from China
2025
·
HUIFANG ZHAO
, Yu Zhu
, et al.
·
Blood
PDF
Supplementary Data 1 from A 5-Year Follow-up Clinical Study of the B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy HDS269B in Patients with Relapsed or Refractory Multiple Myeloma
2024
·
Dongjian Chen
, Yu Zhu
, et al.
Data from A 5-Year Follow-up Clinical Study of the B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy HDS269B in Patients with Relapsed or Refractory Multiple Myeloma
2024
·
Dongjian Chen
, Yu Zhu
, et al.
Supplementary Data 1 from A 5-Year Follow-up Clinical Study of the B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy HDS269B in Patients with Relapsed or Refractory Multiple Myeloma
2024
·
Dongjian Chen
, Yu Zhu
, et al.
Risk factors for cognitive impairment after ischenfic stroke
2012
·
Yu Zhu
, Xinxin Qi
, et al.
·
Int J Cerebrovasc Dis
Show more works
View as search
Works count:
25
Citation count:
124
H-index:
7
I10-index:
6
Year
Topic
Type